查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2018633

動物醫藥市場：2026-2032年全球市場預測（依產品類型、目標動物、治療領域、給藥途徑及通路分類）

Veterinary Medicine Market by Product Type, Animal Type, Therapeutic Area, Route Of Administration, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，獸藥市場價值將達到 491 億美元，到 2026 年將成長至 529.7 億美元，到 2032 年將達到 849.1 億美元，複合年成長率為 8.13%。

主要市場統計數據
基準年 2025 491億美元
預計年份：2026年 529.7億美元
預測年份 2032 849.1億美元
複合年成長率 (%) 8.13%

對不斷發展的動物醫藥生態系統進行簡要概述，重點關注整合醫學、預防策略以及決策者的商業性需求。

獸醫學領域正處於一個轉折點，技術創新、消費者模式的改變以及監管環境的演變正在重塑臨床實踐、產品開發和分銷。本執行摘要簡要概述了高階主管在應對短期挑戰和掌握長期策略機會時應考慮的結構性促進因素、競爭動態及其對業務營運的影響。

診斷主導的護理、數位化管道和本地化供應鏈如何重新定義獸醫領域的產品開發和服務交付。

根本性的變革正在改變獸醫服務的提供方式、產品的研發方式以及商業性價值的創造方式。其中一個重大變革是診斷與治療的融合。快速的即時診斷和先進的影像技術使得早期療育成為可能，進而推動了對標靶藥物和疫苗的需求。利用這些診斷技術的模式正在重塑犬貓等伴侶動物的臨床診療方案，同時也影響牛、家禽和豬等畜群的健康管理策略。

評估 2025 年美國關稅措施對獸藥品類整體供應鏈、採購選擇和價格趨勢的策略影響。

貿易政策和關稅措施的變化將對整個獸藥價值鏈的投入成本、供應鏈策略和價格趨勢產生重大影響。預計美國將於2025年實施或提案徵收關稅，這將再次給製造商和經銷商帶來巨大壓力，迫使他們重新評估活性藥物成分、疫苗組分和診斷設備的籌資策略。這些關稅措施往往會增加進口原料和成品的成本，促使企業探索供應商多元化、近岸外包和長期採購協議等方案。

為了更好地進行決策，我們提供細分市場層面的策略指導，使物種特定需求、產品形式、治療重點、分銷管道和給藥途徑保持一致。

細緻的市場區隔觀點對於將市場趨勢轉化為可執行的商業計劃至關重要。相關人員需要根據動物種類制定差異化的策略：伴侶動物市場，貓狗佔據了大部分臨床需求和消費者支出；以馬為中心的馬匹市場，其性能和健康需求獨具特色；以及畜牧業市場，包括牛、家禽和豬，規模、生物安全和飼料轉化率都會影響產品的採用。每個動物類別都有其獨特的購買模式、監管要點和分銷管道偏好。

影響全球主要地區監管協調、生產決策和分銷策略的區域趨勢和跨境因素。

區域趨勢對整體獸醫行業的管理體制、流通結構和投資重點都產生了顯著影響。美洲地區通常擁有成熟的伴侶動物照護生態系統、強大的零售藥局網路以及日益普及的數位醫療服務。這些特點支撐了都市區較高的單隻動物醫療支出，並為診斷和處方藥創造了極具吸引力的分銷管道。相較之下，歐洲、中東和非洲（EMEA）地區則呈現出多樣性；許多歐洲市場已建立了完善的法規結構和高標準的獸醫體系，而中東和非洲的一些地區則優先考慮畜牧業健康和生物安全，以保護食品供應鏈。

一項結合產品創新、夥伴關係和商業性靈活性的競爭策略，旨在確保臨床應用和獸醫領域的永續成長。

獸醫領域的競爭格局取決於產品系列、垂直整合和策略夥伴關係關係。主要企業往往將疫苗平台、專有藥品和診斷能力等優勢與覆蓋診所、藥房和線上管道的廣泛分銷網路和服務相結合。投資於製劑科學和給藥技術的企業在使用者便利性和用藥依從性方面獲得優勢，尤其是在慢性病治療和驅蟲藥給藥方案製定方面。

一系列可操作的策略措施，重點在於診斷、健全的採購系統、通路差異化、物種特異性研發以及與監管機構的合作，將推動商業化成功。

產業領導企業應優先考慮幾項影響深遠的舉措，以克服複雜性並抓住機會。首先，投資診斷整合和即時數據系統能夠實現更精準的治療決策，減少不合理使用抗生素，並有助於向支付方和終端用戶傳遞價值。這需要協調投資於臨床檢測、影像技術和分析能力，以便將臨床徵兆轉化為可執行的治療方案。

為了獲得可立即用於決策的實用見解，我們採用以證據為基礎的研究途徑，結合質性訪談、二次檢驗和情境壓力測試。

本執行摘要所依據的研究採用了多種調查方法，以確保其可靠性和有效性。主要研究包括：對伴侶動物、馬匹和牲畜領域的獸醫進行結構化訪談；與製藥、疫苗和診斷行業的資深商業領袖進行討論；以及與透過線上、零售藥局和診所管道運營的分銷合作夥伴進行諮詢。這些訪談提供了關於產品推廣促進因素、給藥偏好和通路經濟效益等方面的實地觀點。

本報告將物種特定優先事項、不斷演變的分銷模式和政策主導的供應鏈應對措施聯繫起來，並將它們整合為清晰的策略見解，供領導者參考。

總而言之，獸醫學的格局正在朝著以診斷主導的綜合醫療模式發展，並以數位化管道和在地化生產策略為支持。從貓狗等伴侶動物到馬匹，甚至牛、家禽、豬等生產動物，不同物種的差異需要在產品開發、監管合作和分銷設計等各個階段採取量身定做的方法。產品創新日益著重於增強診斷能力、開發先進的疫苗平台以及研發符合實際應用限制的便利配方。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章動物醫藥市場：依產品類型分類

  • 診斷藥物
    • 診斷影像
    • 感染疾病
  • 藥用飼料添加劑
  • 製藥
    • 學名藥
    • 非處方藥
    • 處方藥
  • 疫苗
    • 失活
    • 活病毒疫苗
    • 重組

第9章動物醫藥市場：依動物類型分類

  • 伴侶動物
    • 貓
    • 狗
  • 馬
  • 家畜
    • 牛
    • 家禽
    • 豬

第10章動物醫藥市場：依治療領域分類

  • 感染疾病物
    • 抗生素
    • 抗真菌藥物
    • 抗病毒藥物
  • 抗發炎藥
  • 循環系統
  • 驅蟲
    • 體外寄生蟲控制藥物
    • 體內寄生蟲控制藥物

第11章動物醫藥市場：依給藥途徑分類

  • 吸入
  • 注射藥物
  • 口服
  • 外用

第12章動物醫藥市場：依分銷管道分類

  • 網路商店
  • 藥局
  • 動物醫院

第13章動物醫藥市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章動物醫藥市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章動物醫藥市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國動物醫藥市場

第17章：中國動物醫藥市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Archer-Daniels-Midland Company
  • Biogenesis Bago SA
  • Biopharm company
  • Biowet Pulawy sp. z oo
  • Brovapharma
  • CH Boehringer Sohn AG & Co KG
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Intracin Pharmaceutical Private Limited
  • JoinHub Pharma
  • Merck & Co Inc.
  • Nam Pharma Sdn Bhd
  • NAPHAVET Co., Ltd.
  • Neogen Corporation
  • Nutreco NV
  • Phibro Animal Health Corporation
  • Sykes Vet International Pty Ltd.
  • TRAVETCO
  • Vetoquinol SA
  • Vetpharma Animal Health SL
  • Vetsintez LLC
  • Virbac SA
  • Weefsel Pharma
  • Zoetis Inc.
Product Code: MRR-221461476D1E

The Veterinary Medicine Market was valued at USD 49.10 billion in 2025 and is projected to grow to USD 52.97 billion in 2026, with a CAGR of 8.13%, reaching USD 84.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 49.10 billion
Estimated Year [2026] USD 52.97 billion
Forecast Year [2032] USD 84.91 billion
CAGR (%) 8.13%

A concise orientation to the evolving veterinary medicine ecosystem emphasizing integrated care, preventive strategies, and commercial imperatives for decision-makers

The veterinary medicine sector stands at an inflection point where technological innovation, shifting consumption patterns, and evolving regulatory landscapes are reshaping clinical practice, product development, and distribution. This executive summary provides a concise synthesis of the structural drivers, competitive dynamics, and operational implications that senior leaders must consider to navigate near-term disruptions and longer-term strategic opportunities.

Over recent years, veterinary care has moved beyond episodic treatment toward integrated animal health management that emphasizes preventive care, diagnostics-led decision making, and data-driven outcomes. These trends are especially pronounced in companion animal care, where pet owners increasingly prioritize convenience, digital engagement, and higher standards of therapeutic outcomes. At the same time, livestock and equine segments are experiencing heightened scrutiny on biosecurity, productivity, and feed efficiency, prompting shifts in product mix and service delivery.

Consequently, corporate leaders must align R&D priorities, go-to-market models, and supply chain resilience with these multi-vector changes. This introduction frames the subsequent sections, which explore transformative shifts across the ecosystem, tariff-related trade implications projected for 2025, segmentation-level insights, regional dynamics, competitive positioning, actionable recommendations, and the research approach underpinning the findings. The narrative purposefully integrates species, product, distribution, therapeutic, and administration dimensions so that stakeholders can translate strategic implications into practical initiatives.

How diagnostics-led care, digital channels, and supply chain localization are redefining product development and service delivery across veterinary medicine

Fundamental shifts are transforming how veterinary health services are delivered, how products are developed, and how commercial value is captured. One major change is the convergence of diagnostics and therapeutics: faster, point-of-care diagnostics and advanced imaging are enabling earlier intervention, which in turn drives demand for targeted pharmaceuticals and vaccines. This diagnostic-enabled model is reshaping clinical protocols for companion animals such as cats and dogs, while also informing herd health strategies for cattle, poultry, and swine.

Another transformative movement is the rapid adoption of digital and remote care models. Telemedicine and digital triage platforms have become a viable complement to traditional clinic visits, particularly in urban companion animal markets and in regions where clinic density is low. These digital capabilities are altering the distribution landscape, creating opportunities for online stores to partner with pharmacies and veterinary clinics to provide integrated care journeys. They also permit more efficient chronic disease management across therapeutic areas such as anti-infectives and anti-inflammatories.

Supply chain localization and manufacturing innovation constitute a third major shift. In response to geopolitical uncertainty and pandemic lessons, firms are accelerating investments in localized formulation and fill-finish capacity, as well as in alternative routes of administration such as injectables, oral formulations, and topical therapies that align with field conditions. Finally, there is a rising emphasis on formulation science and novel vaccine platforms that address species-specific needs-ranging from recombinant vaccines for equine applications to improved inactivated vaccine stability for livestock-thereby changing product development roadmaps and regulatory engagement strategies.

Assessing the strategic consequences of United States tariff measures in 2025 for supply chains, sourcing choices, and pricing dynamics across veterinary product categories

Trade policy changes and tariff actions can materially influence input costs, supply chain strategies, and pricing dynamics across the veterinary medicines value chain. In the context of tariffs enacted or proposed in the United States in 2025, manufacturers and distributors are facing renewed pressure to reassess sourcing strategies for active pharmaceutical ingredients, vaccine components, and diagnostic equipment. These tariff measures tend to increase landed costs for imported raw materials and finished goods, which encourages firms to evaluate options including supplier diversification, nearshoring, and long-term purchasing agreements.

As companies respond, logistics and inventory strategies will also adapt. Firms may increase safety stock levels or shift to multi-sourcing to mitigate exposure, while contract manufacturers and distributors reassess contractual terms to allocate risk more explicitly. In parallel, pricing discipline becomes critical: firms must consider how to balance cost recovery with competitive positioning, especially in price-sensitive channels such as online stores and pharmacies. For therapeutic categories where alternatives exist-such as generic pharmaceuticals versus brand prescription drugs-tariff-induced cost differentials can accelerate substitution or, conversely, reinforce demand for domestically produced branded solutions.

Regulatory and policy responses will further shape outcomes. Policymakers may implement targeted exemptions for essential veterinary products to preserve animal health and food security, or they may incentivize domestic production through tax credits and grants. Therefore, senior leaders should monitor trade policy developments closely while engaging with industry associations and regulatory bodies to advocate for predictable trade frameworks that protect both animal health and sectoral resilience.

Segment-level strategic guidance that aligns species-specific needs, product modalities, therapeutic priorities, distribution channels, and routes of administration for better decision-making

A nuanced segmentation view is indispensable for translating market dynamics into actionable commercial plans. Based on animal type, stakeholders must differentiate strategies across companion animal segments-where cats and dogs dominate clinical demand and consumer spending-from equine markets, which have unique performance and wellness needs centered on horses, and livestock sectors comprising cattle, poultry, and swine where scale, biosecurity, and feed efficiency drive product adoption. Each animal category presents distinct purchasing patterns, regulatory touchpoints, and channel preferences.

Product type segmentation reveals divergent innovation and commercialization pathways. Diagnostics encompass imaging modalities and infectious disease assays that are increasingly deployed at point of care, influencing downstream pharmaceutical and vaccine utilization. Medicated feed additives target production efficiency in livestock, requiring close alignment with feed manufacturers and farm management systems. Pharmaceuticals span generic drugs, over-the-counter remedies, and prescription medicines, each with different regulatory burdens and margin profiles. Vaccines include inactivated, live attenuated, and recombinant platforms, and they demand specialized cold-chain and administration capabilities.

Distribution channel segmentation-consisting of online stores, pharmacies, and veterinary clinics-determines customer access models and margin structures. Online channels excel in convenience and subscription models, pharmacies provide retail reach for OTC products, and clinics combine diagnosis with point-of-care treatment. Therapeutic area distinctions across anti-infectives, anti-inflammatories, cardiovascular agents, and parasiticides inform R&D prioritization; within anti-infectives, antibiotics, antifungals, and antivirals each require targeted stewardship strategies, while parasiticides separate into ectoparasiticides and endectocides with differing administration regimens. Route of administration considerations-covering inhalation, injectable, oral, and topical formats-further influence product design, user training needs, and adoption curves.

Regional dynamics and cross-border considerations that influence regulatory alignment, manufacturing decisions, and distribution strategies across major global regions

Regional dynamics materially shape regulatory regimes, distribution architectures, and investment priorities across veterinary medicine. In the Americas, markets often feature mature companion animal care ecosystems, a strong retail pharmacy presence, and expanding digital health adoption; these characteristics support higher per-animal spend in urban centers and create attractive channels for diagnostics and prescription pharmaceuticals. In contrast, the Europe, Middle East & Africa region displays heterogeneity, with advanced regulatory frameworks and high veterinary standards in many European markets, while certain Middle East and African jurisdictions prioritize livestock health and biosecurity to safeguard food supply chains.

Asia-Pacific is marked by rapid modernization of veterinary services, with growing investment in manufacturing capacity and rising demand for both companion and production animal products. Across all regions, supply chain resilience and regulatory harmonization remain salient priorities, especially for vaccines and biologics that require cold-chain integrity and stringent quality controls. Regional trade agreements and local manufacturing incentives influence where companies choose to site production and distribution hubs, and they affect how firms design market entry strategies that balance speed to market with compliance and cost efficiency.

Consequently, regional leaders and global teams must coordinate closely; successful approaches integrate local market intelligence, regulatory affairs expertise, and partnerships with regional distributors, while also leveraging center-led capabilities in R&D and manufacturing to maintain quality and scale economies.

Competitive strategies that combine product innovation, partnerships, and commercial agility to secure clinical adoption and sustainable growth in veterinary medicine

Competitive positioning in veterinary medicine is shaped by product portfolios, vertical integration, and strategic partnerships. Leading firms tend to combine strengths in vaccine platforms, proprietary pharmaceuticals, and diagnostic capabilities with broad distribution networks and service offerings that span clinics, pharmacies, and online channels. Companies investing in formulation science and delivery technologies secure advantages in user convenience and adherence, particularly for chronic therapeutic areas and parasiticide regimens.

Collaboration remains a key tactic: alliances with feed producers, diagnostic innovators, and contract manufacturing organizations accelerate route-to-market for medicated feed additives and specialty biologics. Licensing and co-development agreements are common for bringing recombinant vaccines and advanced diagnostics to market efficiently, while strategic acquisitions can fill capability gaps in imaging or point-of-care assay technologies. Additionally, firms that proactively engage in antimicrobial stewardship and transparent supply chain practices earn greater trust among regulators, veterinarians, and end customers.

Finally, agility in commercial models-such as subscription services for chronic disease management, bundled diagnostics-therapy offerings for clinics, and direct-to-consumer e-commerce strategies for OTC products-differentiates market leaders from fast followers. Investment in real-world evidence generation and veterinarian education programs further strengthens clinical adoption and long-term brand loyalty.

A pragmatic set of strategic moves focused on diagnostics, resilient sourcing, channel differentiation, species-aligned R&D, and regulatory engagement to drive commercialization success

Industry leaders should prioritize a few high-impact initiatives to navigate complexity and capture opportunities. First, investing in diagnostic integration and real-time data systems will enable more precise therapeutic decisions, reduce inappropriate antimicrobial use, and support value communication to payers and end users. This requires coordinated investments in point-of-care testing, imaging capabilities, and analytics that translate clinical signals into actionable protocols.

Second, companies should reassess sourcing and manufacturing footprints to mitigate tariff and geopolitical risks. Where feasible, nearshoring or dual-sourcing strategies for critical inputs, along with long-term supplier partnerships, will enhance resilience without sacrificing cost competitiveness. Third, firms need to adopt differentiated distribution strategies that exploit the strengths of online channels, pharmacy networks, and clinic relationships; this means creating channel-specific value propositions and service models that reflect distinct customer journeys.

Fourth, aligning R&D pipelines with species-specific needs and administration preferences will improve adoption rates. Prioritizing formulations that simplify administration for owners and farm staff, and advancing vaccine platforms with improved stability, will lower barriers to use. Lastly, proactive regulatory engagement and participation in stewardship initiatives will protect product credibility and enable smoother market access. Together, these actions form a pragmatic roadmap for translating insight into execution.

An evidence-based research approach combining qualitative interviews, secondary validation, and scenario stress-testing to derive practical, decision-ready insights

The research underpinning this executive summary combines multiple methodological approaches to ensure reliability and relevance. Primary qualitative research included structured interviews with veterinarians across companion, equine, and livestock practices, discussions with senior commercial leaders in pharmaceuticals, vaccines, and diagnostics, and consultations with distribution partners operating online, retail pharmacy, and clinic channels. These interviews provided frontline perspectives on adoption drivers, administration preferences, and channel economics.

Secondary analysis drew on peer-reviewed literature, regulatory guidance, industry technical standards, and public company disclosures to validate trends in product innovation, manufacturing capacity, and policy developments. Trade policy and supply chain assessments incorporated publicly available tariff announcements and government statements to model likely operational responses without producing quantitative market estimates. Cross-validation exercises were used to triangulate insights across species, product types, therapeutic areas, and regions to reduce bias and enhance applicability.

Finally, the methodology emphasized practical applicability: findings were stress-tested through scenario workshops with commercial and regulatory experts to refine strategic recommendations and to ensure that suggested actions are feasible within typical organizational constraints and timelines.

Concluding synthesis that links species-specific priorities, evolving distribution models, and policy-driven supply chain responses into clear strategic implications for leaders

In summary, the veterinary medicine landscape is evolving toward integrated, diagnostic-led care supported by digital channels and localized manufacturing strategies. Species differences-from companion animals such as cats and dogs to horses and to production animals like cattle, poultry, and swine-require tailored approaches across product development, regulatory engagement, and distribution design. Product innovation is increasingly centered on diagnostic enablement, advanced vaccine platforms, and user-friendly formulations that match real-world administration constraints.

Trade policy shifts, including tariff actions in major markets, are prompting companies to reconfigure sourcing and inventory strategies while engaging with policymakers to safeguard essential animal health products. Regionally differentiated market dynamics underscore the need for market entry and manufacturing decisions that reflect local regulatory environments and logistical realities across the Americas, Europe, Middle East & Africa, and Asia-Pacific. For commercial leaders, the combination of competitive collaboration, investment in point-of-care capabilities, and disciplined regulatory engagement presents a coherent path to sustain growth and mitigate risk.

Taken together, these conclusions provide a strategic lens for executives to prioritize investments, align cross-functional teams, and accelerate initiatives that deliver measurable improvements in animal health outcomes and organizational resilience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Veterinary Medicine Market, by Product Type

  • 8.1. Diagnostics
    • 8.1.1. Imaging
    • 8.1.2. Infectious Disease
  • 8.2. Medicated Feed Additives
  • 8.3. Pharmaceuticals
    • 8.3.1. Generic Drugs
    • 8.3.2. Over The Counter Drugs
    • 8.3.3. Prescription Drugs
  • 8.4. Vaccines
    • 8.4.1. Inactivated
    • 8.4.2. Live Attenuated
    • 8.4.3. Recombinant

9. Veterinary Medicine Market, by Animal Type

  • 9.1. Companion Animal
    • 9.1.1. Cat
    • 9.1.2. Dog
  • 9.2. Equine
  • 9.3. Livestock
    • 9.3.1. Cattle
    • 9.3.2. Poultry
    • 9.3.3. Swine

10. Veterinary Medicine Market, by Therapeutic Area

  • 10.1. Anti Infectives
    • 10.1.1. Antibiotics
    • 10.1.2. Antifungals
    • 10.1.3. Antivirals
  • 10.2. Anti Inflammatories
  • 10.3. Cardiovascular
  • 10.4. Parasiticides
    • 10.4.1. Ectoparasiticides
    • 10.4.2. Endectocides

11. Veterinary Medicine Market, by Route Of Administration

  • 11.1. Inhalation
  • 11.2. Injectable
  • 11.3. Oral
  • 11.4. Topical

12. Veterinary Medicine Market, by Distribution Channel

  • 12.1. Online Stores
  • 12.2. Pharmacies
  • 12.3. Veterinary Clinics

13. Veterinary Medicine Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Veterinary Medicine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Veterinary Medicine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Veterinary Medicine Market

17. China Veterinary Medicine Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Archer-Daniels-Midland Company
  • 18.6. Biogenesis Bago SA
  • 18.7. Biopharm company
  • 18.8. Biowet Pulawy sp. z o.o.
  • 18.9. Brovapharma
  • 18.10. C H Boehringer Sohn AG & Co KG
  • 18.11. Ceva Sante Animale
  • 18.12. Dechra Pharmaceuticals PLC
  • 18.13. Elanco Animal Health Incorporated
  • 18.14. Evonik Industries AG
  • 18.15. Hester Biosciences Limited
  • 18.16. Indian Immunologicals Ltd.
  • 18.17. Intracin Pharmaceutical Private Limited
  • 18.18. JoinHub Pharma
  • 18.19. Merck & Co Inc.
  • 18.20. Nam Pharma Sdn Bhd
  • 18.21. NAPHAVET Co., Ltd.
  • 18.22. Neogen Corporation
  • 18.23. Nutreco NV
  • 18.24. Phibro Animal Health Corporation
  • 18.25. Sykes Vet International Pty Ltd.
  • 18.26. TRAVETCO
  • 18.27. Vetoquinol SA
  • 18.28. Vetpharma Animal Health S.L.
  • 18.29. Vetsintez LLC
  • 18.30. Virbac SA
  • 18.31. Weefsel Pharma
  • 18.32. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VETERINARY MEDICINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VETERINARY MEDICINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GENERIC DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY OVER THE COUNTER DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY RECOMBINANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CAT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DOG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY EQUINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIFUNGALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTIVIRALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ANTI INFLAMMATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ECTOPARASITICIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ENDECTOCIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INHALATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY ONLINE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 241. GCC VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 242. GCC VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 244. GCC VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 245. GCC VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 246. GCC VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. GCC VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 248. GCC VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 249. GCC VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 250. GCC VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 251. GCC VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 252. GCC VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 253. GCC VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 280. G7 VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. G7 VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 282. G7 VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 284. G7 VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 285. G7 VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. G7 VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 287. G7 VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 288. G7 VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 289. G7 VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 290. G7 VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 291. G7 VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 292. G7 VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. NATO VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 294. NATO VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. NATO VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 296. NATO VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 297. NATO VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 298. NATO VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. NATO VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 300. NATO VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 301. NATO VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 302. NATO VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 303. NATO VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 304. NATO VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 305. NATO VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL VETERINARY MEDICINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA VETERINARY MEDICINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA VETERINARY MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA VETERINARY MEDICINE MARKET SIZE, BY DIAGNOSTICS, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA VETERINARY MEDICINE MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA VETERINARY MEDICINE MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA VETERINARY MEDICINE MARKET SIZE, BY ANIMAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA VETERINARY MEDICINE MARKET SIZE, BY COMPANION ANIMAL, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA VETERINARY MEDICINE MARKET SIZE, BY LIVESTOCK, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA VETERINARY MEDICINE MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA VETERINARY MEDICINE MARKET SIZE, BY ANTI INFECTIVES, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA VETERINARY MEDICINE MARKET SIZE, BY PARASITICIDES, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA VETERINARY MEDICINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA VETERINARY MEDICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)